XOMA (NASDAQ:XOMAO – Get Free Report) is expected to post its resultson Thursday, July 30th. Analysts expect XOMA to announce earnings of $0.1761 per share and revenue of $13.91 million for the quarter.
XOMA Price Performance
NASDAQ:XOMAO opened at $25.00 on Wednesday. XOMA has a 52-week low of $24.86 and a 52-week high of $26.40. The stock has a fifty day simple moving average of $25.24 and a 200-day simple moving average of $25.36.
XOMA Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, July 14th. Investors of record on Thursday, July 2nd were paid a $0.5234 dividend. This represents a $2.09 dividend on an annualized basis and a yield of 8.4%. The ex-dividend date of this dividend was Thursday, July 2nd.
XOMA Company Profile
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Featured Stories
- Five stocks we like better than XOMA
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
